AC Immune (ACIU) IPO Opens Up 28%

September 23, 2016 10:31 AM EDT
Get Alerts ACIU Hot Sheet
Trade ACIU Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Today's IPO for AC Immune SA (NASDAQ: ACIU) opened for trading at $14.10 after pricing its initial public offering of 6,000,000 of its common shares at the initial public offering price of $11.00 per common share, the low end of the expected $11-$13 range. This represents a 32% increase in the offering size relative to the originally announced amount of 4,545,456 common shares

Credit Suisse Securities (USA) LLC, Jefferies LLC and Leerink Partners LLC are acting as joint book-running managers for the proposed offering.

AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with four product candidates in clinical trials. The Company designs, discovers and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot IPOs, IPOs

Related Entities

Credit Suisse, Jefferies & Co, IPO

Add Your Comment